These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 7235792

  • 1. Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.
    Anderson JL, Popat KD, Pitt B.
    Arch Intern Med; 1981 May; 141(6):801-2. PubMed ID: 7235792
    [Abstract] [Full Text] [Related]

  • 2. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL.
    Clin Ther; 1985 May; 7(2):205-24. PubMed ID: 3886143
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of refractory ventricular tachycardia and fibrillation by bretylium tosylate: a report of 4 cases].
    Li SZ, Xu XH.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Aug; 15(4):203-4, 12. PubMed ID: 3440418
    [No Abstract] [Full Text] [Related]

  • 4. Massive intravenous bolus bretylium tosylate.
    Bodnar T, Nowak R, Tomlanovich MC.
    Ann Emerg Med; 1980 Dec; 9(12):630-3. PubMed ID: 7447102
    [Abstract] [Full Text] [Related]

  • 5. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW, Pickron J, Goldman AM.
    Heart Lung; 1980 Dec; 9(2):265-70. PubMed ID: 6898604
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH, Bigger JT.
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Experimental and clinical effects of bretylium tosylate on ventricular fibrillation, arrhythmias, and heart block.
    Bacaner M.
    Geriatrics; 1971 Jan; 26(1):132-48. PubMed ID: 5539447
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD, Rizk AE, Wright KE.
    Heart Lung; 1979 Jan; 8(4):721-7. PubMed ID: 378903
    [No Abstract] [Full Text] [Related]

  • 14. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL, Patterson E, Wagner JG, Johnson TA, Lucchesi BR, Pitt B.
    J Cardiovasc Pharmacol; 1981 Jan; 3(3):485-99. PubMed ID: 6168830
    [Abstract] [Full Text] [Related]

  • 15. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M, Rdzanek H, Zochowski RJ.
    Pol Tyg Lek; 1981 Jan; 47(40-41):901-4. PubMed ID: 1341893
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug therapy: bretylium.
    Koch-Weser J.
    N Engl J Med; 1979 Mar 01; 300(9):473-7. PubMed ID: 366419
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E, Gibson JK.
    Circulation; 1981 Nov 01; 64(5):1045-50. PubMed ID: 7285294
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.